Publications

In October 1999, a 28-year-old woman sustained severe injuries to her lower extremities in an automobile accident, after which she underwent reconstructive surgery. In December 1999, she again underwent surgery for removal of metallic objects from her legs, followed by a knee arthroscopic procedure in January 2000. In August 2001, she was diagnosed with a brain abscess that was drained, and subsequently treated with intravenous antibiotics. In January 2002, she was treated for infectious mononucleosis. In March 2002, she was diagnosed with polytoxicomania (benzodiazepine and synthetic opiate dependency), and subsequently treated for withdrawal symptoms.

In May 2002, the patient was diagnosed with cervical intraepithelial neoplasia and treated with conization and cryocoagulation. Over the following months, she also received treatments including cytostatic (Endoxan, [Baxter, Germany], Cysplatyl [Aventis, France], Vinblastin [Mayne Pharma], Cosmegen [Merck, Whitehouse Station NJ]), antihormone (Zitazonium [Egis, Hungary], Honvan [Baxter]), and interferon (Intron A [Shering-Plough], Egiferon [Trigon, Germany]) therapies. The patient experienced the side-effects of nausea, vomiting, and severe pain in the extremities, and reported alternating episodes of diarrhea and constipation. She lost weight, felt bone pain, and was fatigued. Hemoptysis and menorrhagia was noted also.

In July 2002, blood test results indicated thrombocytopenia, elevated white cell counts, and anemia. In September 2002, a growth appeared on the right upper arm. Pathologic examination confirmed an unclassified soft tissue malignancy, and the growth was resected. Subsequently, nodules appeared under the armpits, on the neck and around the genitalia. At the beginning of October 2002, a whole body computed tomography scan was performed.

Numerous soft tissue tumors (the exact numbers could not be determined) around 1 cm in diameter were detected throughout the body. The highest density was in the lower abdomen, underneath the right side of the rib cage as well as the right side of the spine. Significant fluid accumulation was detected in the pelvic area. At that point, the patient opted out of conventional therapies and, beginning October 2002, began a 1-month course of the MSQ-13 oral dietary composition. This composition was developed in response to the discovery that a number of coincidental critical nutrient deficiencies exist in cancer patients. The active ingredients of the dietary composition are blackstrap molasses, apple cider vinegar, quinine, sulfur, rose oil, folic acid, vitamin B₁₂, and molecular iodine. The dosage was 2 tbsp t.i.d. po taken with meals. Ample consumption of purified water with this formula is recommended.

The patient, who had difficulties swallowing, could only take half the recommended dose of MSQ-13. Despite this, some improvement in the complete blood count (CBC) was observed by late November 2002 (Table 1) and some regression of visible tumors located along the spine was noted. At the end of November 2002, an abrupt leukemic crisis occurred. The patient’s red blood cell (RBC) and platelet counts sharply declined, whereas white cells numbers surged (see Table 1). Bone marrow pathology confirmed the presence of erythroid blast cells in the bone marrow, which also were observed in the peripheral blood.

The patient then presented with constant fever (>38°C), vomiting, episodes of alternating high and low blood pressure, elevated pulse rate, sweating and shortness of breath, bleeding, and periodic loss of consciousness. For the next month, she could only sporadically take the MSQ. She received parenteral nutrition with vitamin and mineral supplementation. In the middle of January 2003, blast cell concentration in the marrow was 54%, and the patient also presented with bacteriuria (>100,000 cfu/mL) and proteinuria (>500 mg/24 h).

Oral feeding was resumed with the aid of a fresh fruit concentrate and by the end of January 2003 the patient resumed taking the MSQ. This time she received the more active MSQ15 formula (2 tbsp t.i.d.), which contains the additional ingredients of baking soda, prune juice, and sucrose.

By late February 2003, there was a surge in RBC and platelet counts and a decline in white blood cells (see Table 1). Blood enzymes and metabolites returned to the normal range. Blast cells disappeared from the bone marrow and peripheral blood, all the soft tissue tumors regressed, and the pathologic urinary symptoms reversed. All the clinical manifestations of AML had resolved, and the patient had a complete remission.

The patient was stable until the end of September 2004, when she presented with menorrhagia and an elevated carcinoembryonic antigen. She also was fatigued and had episodes of high fever (>38°C), sweating, shortness of breath, and periodic loss of consciousness. Enlarged lymph nodes appeared on the neck and under the armpits. Bone marrow pathology confirmed a recurrent AML. Because recurrent cancers frequently exhibit resistance to previous therapies, the authors reasoned that a more active version of MSQ should be administered. Therefore, it was recommended that the MSQ-18 dietary composition contain ground red pepper, ground raw almonds, corn oil, and fresh pineapple juice as additional ingredients.

The patient started on MSQ-18 (2 tbsp t.i.d.) on October 16, 2004. Her CBC was tested at 3to 5-day intervals until the end of November 2004 and, biweekly afterward (see Table 1). In the beginning of the therapy the patient was severely anemic, exhibiting low platelet and high white blood cell (WBC) counts. In just 2 weeks from the onset of the MSQ-18 administration, RBC and platelet counts began to rise, whereas WBC counts were declining. Over a period of 2 months, the CBC has returned to normal and the clinical manifestations of AML resolved. A complete remission was achieved again.